Pasar al contenido principal

OPTIMIZACION DE BEBIDAS SIMBIOTICAS ENRIQUECIDAS EN COMPUESTOS BIOACTIVOS Y EFECTO EN PATOLOGIAS RELACIONADAS CON EL ENVEJECIMIENTO

PID2020-119630RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Characterization and stabilization of the α-L-fucosidase set from Lacticaseibacillus rhamnosus INIA P603

  • Curiel, José Antonio
  • Peirotén, Ángela
  • Langa, Susana
  • Vega, Estela
  • Blasco, Laura
  • Landete, José María
This study describes the molecular identification, biochemical characterization, and stabilization of three recombinant AlfA, AlfB, and AlfC fucosidases from Lacticaseibacillus rhamnosus INIA P603. Even though previous studies revealed the presence of fucosidase activity in L. rhamnosus extracts, the identification of the fucosidases, their physicochemical properties, and the substrate spectrum remained unknown. Although the presence of alfB is not common in strains of L. rhamnosus, fucosidases from L. rhamnosus INIA P603 were selected because this strain exhibited higher fucosidase activity in culture and the complete set of fucosidases. A high yield of purified recombinant AlfA, AlfB, and AlfC fucosidases was obtained (8, 12, and 18 mg, respectively). AlfA, AlfB, and AlfC showed their optimal activities at pH 5.0 and 4.0 at 60 °C, 40 °C, and 50 °C, respectively. Unlike 3-fucosyllactose, all three recombinant fucosidases were able to hydrolyze 2′-fucosyllactose (2′-FL), and their activities were improved through their immobilization on agarose supports. Nevertheless, immobilized AlfB exhibited the highest hydrolysis, releasing 39.6 µmol of fucose mg enzyme−1 min−1. Only the immobilized AlfB was able to synthetize 2′-FL. In conclusion, the enzymatic properties elucidated in this study support the potential ability of fucosidases from L. rhamnosus INIA P603 to hydrolyze fucosylated substrates as well as justifying interest for further research into AlfB for its application to catalyze the synthesis of fucosylated prebiotics., This research was funded by the Spanish Ministry of Science and Innovation grants PID2020-119630RB-I00 and RYC2019-026368-I., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Characterization and stabilization of GluLm and its application to deglycosylate dietary flavonoids and lignans

  • Curiel, José Antonio
  • Ruiz de la Bastida, Ana
  • Langa, Susana
  • Peirotén, Ángela
  • Landete, José María
12 Pág., This study describes the characterization of the recombinant GH3 aryl-β-glucosidase "GluLm" from Limosilactobacillus mucosae INIA P508, followed by its immobilization on an agarose support with the aim of developing an efficient application to increase the availability and concentration of flavonoid and lignan aglycones in a vegetal beverage. In previous studies, heterologous GluLm-producing strains demonstrated a great capacity to deglycosylate flavonoids. Nevertheless, the physicochemical properties and substrate spectrum of the enzyme remained unknown up to now. A high production of purified GluLm was achieved (14 mg L-1). GluLm exhibited optimal activity at broad ranges of pH (5.0-8.0) and temperature (25-60°C), as well as high affinity (Km of 0.10 mmol L-1) and specific constant (86554.0 mmol L-1 s-1) against p-nitrophenyl-β-D-glucopyranoside. Similar to other GH3 β-glucosidases described in lactic acid bacteria, GluLm exhibited β-xylosidase, β-galactosidase, and β-fucosidase activities. However, this study has revealed for the first time that a GH3 β-glucosidase is capable to hydrolyze different families of glycosylated phenolics such as flavonoids and secoiridoids. Although it exhibited low thermal stability, immobilization of GluLm improved its thermostability and allowed the development of a beverage based on soybeans and flaxseed extract with high concentration of bioactive isoflavone (daidzein, genistein), lignan (secoisolariciresinol, pinoresinol, and matairesinol), and other flavonoid aglycones. KEY POINTS: • Limosilactobacillus mucosae INIA P508 GluLm was purified and biochemically characterized • Immobilized GluLm efficiently deglycosylated flavonoids and lignans from a vegetal beverage • A viable application to produce vegetal beverages with a high content of aglycones is described., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This research was funded by the Spanish Ministry of Science and Innovation grants PID2020-119630RB-I00, RYC2019-026368-I, and by CSIC grant 202240I177 belonging to “Ayudas de Incorporación a Científicos Titulares.” A.R.d.l.B. is recipient of a pre-doctoral contract (PRE2018-086293), both from the Spanish Ministry of Science and Innovation., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

The first complete genome of Fructilactobacillus vespulae: strain Mu01, isolated from nectar of Musa paradisiaca L. [Dataset]

  • Zúñiga, Manuel
  • Alcántara, Cristina
  • Peirotén, Ángela
  • Ramón Nuñez, Luis Andrés
  • Monedero, Vicente
  • Landete, José María
FigureS1.pdf: Maximum likelihood phylogenetic tree of F. vespulae Mu01 and closely related species. -- datafile 4.fas: Concatenated alignment of 20 core protein sequences from F. vespulae Mu01 and closely related species used for the phylogenetic reconstruction. --Figures_S2_S3.pdf: Maps of chromosome and pFVMP1 plasmid of F. vespulae Mu01 --Table_S1.xlsx: Summary of Mu01 CRISPR-cas system. --Table_S2.xlsx Summary of Mu01 prophage genetic characteristics. --Tables_S3_S4.pdf: Summary of phenotypic characteristics of Mu01., A novel strain of Fructilactobacillus vespulae was isolated from nectar of Musa paradisiaca L. during a survey for LAB associated with wild and cultivated plants in the metropolitan area of Valencia, Spain. A complete genome was obtained by sequencing with Nanopore long read technology. The genome consists of a chromosome of 1506092 bp and a plasmid of 42437 bp, presenting a GC content of 36 % and 31 %, respectively. The genome includes 1541 genes, with 1450 CDSs, 7 pseudogenes, 18 rRNA encoding genes, 63 tRNAs and 3 ncRNAs., This work was partially financed by the Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación, Spain, through project PID2020-119630RB-I00., With funding from the Spanish goverment through the "Severo Ochoa Centre of Excellence" accreditation (CEX 2021-001189-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

The first complete genome of Fructilactobacillus vespulae: strain Mu01, isolated from nectar of Musa paradisiaca L

  • Zúñiga, Manuel
  • Alcántara, Cristina
  • Peirotén, Ángela
  • Ramón-Nuñez, Luis Andrés
  • Monedero, Vicente
  • Landete, José María
Lactobacillales, commonly known as lactic acid bacteria (LAB), is an order of Gram-positive, facultatively anaerobic or microaerophilic bacteria characterized by their ability to ferment carbohydrates and produce lactic acid as a major metabolic byproduct. Many species within this group have significant roles in food fermentation, human health, and industrial applications. Here, we report the complete genome sequence of Fructilactobacillus vespulae Mu01, the first sequenced genome of this species. The complete genome sequence of F. vespulae Mu01 is expected to provide valuable insights into the genetics and metabolism of this little-characterized species., This work was partially financed by the Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación, Spain, through project PID2020-119630RB-I00., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

GABA- and riboflavin-enriched soy and oat beverages using selected lactic acid bacteria

  • Langa, Susana
  • Ángela Peirotén
  • Susana Rodríguez
  • Vicente Monedero
  • Manuel Zúñiga
  • Curiel, José Antonio
  • Jose Maria Landete
Gamma-aminobutyric acid (GABA) and riboflavin have received significant attention as attractive bioactive compounds with attributed health-promoting properties, including antidepressant and neuroprotective effects. This study aimed to develop soy and oat beverages enriched in GABA and riboflavin through fermentation with specific lactic acid bacteria (LAB) strains. The screening of LAB producers of bioactive compounds concluded with the identification of new riboflavin-producing LAB strains, including for the first time the species Fructobacillus tropaeoli. Nevertheless, since spontaneous strains resistant to roseoflavin showed the ability to overproduce riboflavin, four mutants of Lactiplantibacillus plantarum and Limosilactobacillus fermentum were selected. Additionally, four strains belonging to the species L. plantarum and Lactococcus lactis were selected as high GABA producers. Soy and oat beverages supplemented with 0.2 % monosodium glutamate, as precursor of GABA, and inoculated with the selected single strains were fermented for 48 h at their optimal temperature (30 °C or 37 °C). Riboflavin and GABA production, as well as glutamate utilization, were determined after fermentation, leading to the selection of the riboflavin-overproducing mutant L. plantarum Al03R3 and GABA-producing L. lactis INIA Z174 for co-culture. Fermentation with this combination of strains produced fermented soy and oat beverages enriched with both GABA and riboflavin. Notably, the oat beverage exhibited particularly high yields, reaching 0.98 g/L of GABA and 4.72 mg/L of riboflavin, making it a suitable functional drink for delivering these health-promoting compounds., This work was supported by project PID2020-119630RB-I00 from the Spanish Ministry of Science and Innovation., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The Translational Coupling of Daidzein Reductase and Dihydrodaidzein Racemase Genes Improves the Production of Equol and Its Analogous Derivatives in Engineered Lactic Acid Bacteria

  • Langa, Susana
  • Curiel, José Antonio
  • Peirotén, Ángela
  • Landete, José María
Equol (EQ) and its analogous derivatives 5-hydroxy-equol (5-OH-EQ) and 5-hydroxy-dehydroequol (5-OH-D-EQ) are isoflavones which benefit human health. They are produced from daidzein and genistein, respectively, in the gut by microorganisms harboring the genes daidzein reductase (dzr), dihydrodaidzein racemase (ifcA), dihydrodaidzein reductase (ddr) and tetrahydrodaidzein reductase (tdr). Since the production of these isoflavones is of interest due to their great-health benefits for humans, the heterologous expression of dzr, ddr, tdr and ifcA from Slackia isoflavoniconvertenes DSM 22006T in lactic acid bacteria (LAB) was used as a strategy to produce EQ, 5-OH-EQ and 5-OH-D-EQ in soy beverages. However, efficient production of these compounds was only demonstrated in two engineered Limosilactobacillus fermentum strains, and it is dependent on dihydrodaidzein racemase (DDRC). In order to increase the production of EQ and its analogous derivatives in different LAB species and genera, different strategies were performed with the ifcA gene. Translational coupling of ifcA and dzr genes (pNZ:TuR.dzr.ifcA) under the influence of a constitutive promoter improved the efficiency of production of EQ, 5-OH-EQ and 5-OH-D-EQ in the engineered LAB strains. The translational coupling of ifcA and dzr genes allowed the production of high concentrations of eq (111.15 ± 9.20–410.56 ± 24.15 μM), 5-OH-eq (71.00 ± 4.25 μM–148.22 ± 9.15 μM) and 5-OH-D-eq (111.15 ± 9.20–201.09 ± 7.65 μM) in soy beverages by different engineered LAB genera, such as L. fermentum INIA 584L, Lactilactobacillus plantarum WCFS1, and Lactocaseibacillus paracasei BL23. Translational coupling has allowed engineered Laboratories strains belonging to different genera, such as L. fermentum, L. plantarum, and L. paracasei, to produce high concentrations of EQ, 5-OH-EQ and 5-OH-D-EQ. Translational coupling could be exploited as a strategy for the efficient production of bioactive compounds., PID2020-119630RB Project from the Spanish Ministry of Science and Innovation provided funding for this work. We are appreciative of the mass spectrometry and chromatography facilities provided by the Analysis Services Unit of the ICTAN (CSIC, Madrid, Spain)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Phenotypic differences between equol-producing and non-equol-producing intestinal microbiota

  • Curiel, José Antonio
  • Langa, Susana
  • Ruiz de la Bastida, Ana
  • Peirotén, Ángela
  • Álvarez Acero, Inmaculada
  • Landete, José María
Equol is an isoflavone produced by intestinal microbiota from daidzein. It has been assumed that individuals with equol-producing microbiota are those who mainly benefit from isoflavone consumption. However, no obvious genotypic differences can be found between the microbiota of equol-producing individuals and non-equol-producing individuals. The aim of this work was to find phenotypic differences in isoflavone metabolism between equol-producing and non-equol-producing intestinal microbiota. Of the 17 faecal samples used in this work, six produced equol from both daidzein and dihydrodaidzein (DHD); however, only equol-producing faecal samples produced 5-hydroxy-equol from genistein and dihydrogenistein (DHG). The equol producing microbiota metabolised most of daidzein, genistein, DHD and DHG present in the medium, while the metabolism of daidzein and genistein by non-equol producing microbiota is much lower, and they do not metabolise DHD and DHG. Moreover, equol-producing faecal samples produced lower concentrations of O-DMA than the non-equol-producing faecal samples. In addition, we demonstrated that most of the O-DMA is produced from daidzein. Therefore, there are important phenotypic differences between equol-producing and non-equol-producing intestinal microbiota, and these differences explain the differentiation between equol-producing and non-equol-producing individuals, and help to understand the metabolism of isoflavones by microbiota and how intestinal microbiota is responsible for the benefits of isoflavone intake., Project PID2020-119630RB-I00 from the Spanish Ministry of Science and Innovation provided funding for this work. Pre-doctoral contract (PRE2018-086293) awarded to A.R.d.l.B. We are appreciative of the mass spectrometry and chromatography facilities provided by the Analysis Services Unit of the ICTAN (CSIC, Madrid, Spain)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Importance of interaction between the matrix effect and microbial metabolism in the bioavailability of lignans

  • Langa, Susana
  • Curiel, José Antonio
  • Ruiz de la Bastida, Ana
  • Peirotén, Ángela
  • Landete, José María
[Backgroung] Plant-lignans are polyphenols with low bioavailability and bioactivity that are transformed by the intestinal microbiota into enterolignans. Our hypotheses are: (i) the way in which plant-lignans are ingested in the diet affects, in a decisive way, the microbial metabolism of these compounds and (ii) an increase in lignan bioaccessibility will produce an increase in enterolignans produced by the intestinal microbiota, increasing the bioavailability of lignans ingested in the diet. Therefore, our aims were to determine how the matrix effect affects the metabolism of lignans by the intestinal microbiota and how improving the bioaccessibility of lignans ingested in the diet improves their bioavailability., [Results] Human faecal samples showed close to 50 times higher efficiency in the production of enterolactone (ENL) from secoisolariciresinol than from flaxseed extracts. ENL is the main enterolignan produced by the intestinal microbiota, and it is mainly produced from dihydroxy-ENL (DHENL) via hydroxy-ENL (HENL). Moreover, the human faecal samples were able to hydrogenate and hydroxylate the ENL. On the other hand, the fermentation of a lignan-enriched food by Bifidobacterium pseudocatenulatum INIA P815 increased the concentration of lignans in the plasma and liver of mice that consumed a diet rich in lignans. DHENL, HENL and ENL showed the highest bioavailability., [Conclusion] The matrix effect is a determining factor in the bioaccessibility and the efficiency of transformation of lignans into enterolignans by the intestinal microbiota. The reduction of the matrix effect increases the production of enterolignans (DHENL, HENL and ENL) by the intestinal microbiota, increasing the bioavailability of ingested lignans. © 2025 The Author(s). Journal of the Science of Food and Agriculture published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry., Project PID2020-119630RB-I00 from the Spanish Ministry of Science and Innovation provided funding for this work. Pre-doctoral contract (PRE2018-086293) awarded to ARdlB. We are appreciative of the mass spectrometry and chromatography facilities provided by the Analysis Services Unit of the ICTAN (CSIC, Madrid, Spain)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Heterologous expression as a tool to increase GABA and riboflavin production in fermented vegetable beverages

  • Langa, Susana
  • Flores, José Antonio
  • Peirotén, Ángela
  • Monedero, Vicente
  • Zúñiga, Manuel
  • Curiel, José Antonio
  • Landete, José María
Gamma-aminobutyric acid (GABA) and riboflavin are bioactive compounds with health-promoting properties that can be produced by particular lactic acid bacteria (LAB) strains. GABA synthesis from glutamate involves the enzyme glutamate decarboxylase and the glutamate/GABA antiporter encoded by gadB and gadC, respectively, albeit yields are not usually high. In this study, different strategies were applied for obtaining fermented vegetable beverages enriched with high yields of both riboflavin and GABA. First, it was explored the construction and selection of LAB engineered to overexpress the gadB and/or gadC genes, and their effects on fermented plant-based beverages to enhance GABA production. For this, we designed the plasmids pNZ:TuR.gadB, pNZ:TuR.gadC and pNZ:TuR.gadCB to heterologously overexpress gadB, gadC or both genes, respectively, for increasing GABA production in different GABA- and/or riboflavin-producing LAB strains and this production was confirmed in broth media and vegetable beverages supplemented with glutamate. Subsequently, selected engineered strains producing high GABA yields were co-cultured in plant-based beverages with a riboflavin-overproducing Lactococcus lactis strain, obtaining increased GABA production in some combinations, but with reduced riboflavin yields. Thus, Lactiplantibacillus plantarum Al03R3, a riboflavin-overproducing spontaneous mutant harboring pNZ:TuR.gadB, was finally selected as the best starter for vegetable beverages due to its double ability to improve GABA (11 g/L) and riboflavin (6 mg/L) yields in fermented oat beverages with increasing monosodium glutamate supplementation between 80 and 150 mM. In conclusion, the implementation of the designed heterologous expression systems in a riboflavin-overproducing strain gave rise a fermented plant-based beverage with high concentrations of both GABA and riboflavin., This work was supported by project PID2020-119630RB-I00 from the Spanish Ministry of Science and Innovation., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed